The DOI matches its Crossref record; 319 of the 319 references it cites were found in a registry or an index.
The Role of Resveratrol in Cancer Therapy
Open accessAbstract
Natural product compounds have recently attracted significant attention from the scientific community for their potent effects against inflammation-driven diseases, including cancer. A significant amount of research, including preclinical, clinical, and epidemiological studies, has indicated that dietary consumption of polyphenols, found at high levels in cereals, pulses, vegetables, and fruits, may prevent the evolution of an array of diseases, including cancer. Cancer development is a carefully orchestrated progression where normal cells acquires mutations in their genetic makeup, which cause the cells to continuously grow, colonize, and metastasize to other organs such as the liver, lungs, colon, and brain. Compounds that modulate these oncogenic processes can be considered as potential anti-cancer agents that may ultimately make it to clinical application. Resveratrol, a natural stilbene and a non-flavonoid polyphenol, is a phytoestrogen that possesses anti-oxidant, anti-inflammatory, cardioprotective, and anti-cancer properties. It has been reported that resveratrol can reverse multidrug resistance in cancer cells, and, when used in combination with clinically used drugs, it can sensitize cancer cells to standard chemotherapeutic agents. Several novel analogs of resveratrol have been developed with improved anti-cancer activity, bioavailability, and pharmacokinetic profile. The current focus of this review is resveratrol’s in vivo and in vitro effects in a variety of cancers, and intracellular molecular targets modulated by this polyphenol. This is also accompanied by a comprehensive update of the various clinical trials that have demonstrated it to be a promising therapeutic and chemopreventive agent.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
2 retracted
Roy, P., Kalra, N., Prasad, S., George, J., & Shukla, Y. (2008) · Pharmaceutical Research · doi:10.1007/s11095-008-9723-z · Cited by 109
RetractedKalra, N., Roy, P., Prasad, S., & Shukla, Y. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.11.006 · Cited by 93
RetractedSiegel, R. L., Miller, K. D., & Jemal, A. (2017) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21387 · Cited by 14,712
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
Natural products as sources of new drugs from 1981 to 2014
Newman, D. J., & Cragg, G. M. (2016) · Journal of Natural Products · doi:10.1021/acs.jnatprod.5b01055 · Cited by 5,858
Hengartner, M. O. (2000) · Nature · doi:10.1038/35037710 · Cited by 5,779
Cancer chemopreventive activity of resveratrol, a natural product derived from grapes
Jang, M., Cai, L., Udeani, G. O., Slowing, K. V., Thomas, C. F., Beecher, C. W. W., Fong, H. H. S., Farnsworth, N. R., Kinghorn, A. D., Mehta, R. G., et al. (1997) · Science · doi:10.1126/science.275.5297.218 · Cited by 4,935 · cited 11×
“Skin DMBA/TPA model in female CD-1 mice 1, 5, 10, 25 μmol topically twice/week for 18 weeks Incidence↓ Number of tumors per mouse↓ [46]”
BackgroundMethodInfluentialA Perspective on Cancer Cell Metastasis
Chaffer, C. L., & Weinberg, R. A. (2011) · Science · doi:10.1126/science.1203543 · Cited by 4,807
STATs in cancer inflammation and immunity: a leading role for STAT3
Yu, H., Pardoll, D., & Jove, R. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2734 · Cited by 4,383
Resveratrol improves health and survival of mice on a high-calorie diet
Baur, J. A., Pearson, K. J., Price, N. L., Jamieson, H. A., Lerin, C., Kalra, A., Prabhu, V. V., Allard, J. S., Lopez-Lluch, G., Lewis, K., et al. (2006) · Nature · doi:10.1038/nature05354 · Cited by 4,290
Wine, alcohol, platelets, and the French paradox for coronary heart disease
Renaud, S., & de Lorgeril, M. (1992) · The Lancet · doi:10.1016/0140-6736(92)91277-f · Cited by 3,643
Du, C., Fang, M., Li, Y., Li, L., & Wang, X. (2000) · Cell · doi:10.1016/s0092-8674(00)00008-8 · Cited by 3,513
Yang, Y., Li, S., Yang, Q., Shi, Y., Zheng, M., Liu, Y., Chen, F., Song, G., Xu, H., Wan, T., et al. (2014) · Cellular Physiology and Biochemistry · doi:10.1159/000358696 · Cited by 3,253
The complexity of NF-κB signaling in inflammation and cancer
Hoesel, B., & Schmid, J. A. (2013) · Molecular Cancer · doi:10.1186/1476-4598-12-86 · Cited by 3,165
Role of Transforming Growth Factor β in Human Disease
Blobe, G. C., Schiemann, W. P., & Lodish, H. F. (2000) · New England Journal of Medicine · doi:10.1056/nejm200005043421807 · Cited by 2,427
Nicholson, D. W., & Thornberry, N. A. (1997) · Trends in Biochemical Sciences · doi:10.1016/s0968-0004(97)01085-2 · Cited by 2,409
The Endogenous Hormones and Breast Cancer Collaborative Group (2002) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/94.8.606 · Cited by 1,793
Renehan, A. G., Zwahlen, M., Minder, C., O'Dwyer, S. T., Shalet, S. M., & Egger, M. (2004) · The Lancet · doi:10.1016/s0140-6736(04)16044-3 · Cited by 1,697
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
Aggarwal, B. B., Bhardwaj, A., Aggarwal, R. S., Seeram, N. P., Shishodia, S., & Takada, Y. (2004) · PubMed · Cited by 1,605
Matrix Metalloproteinases: Biologic Activity and Clinical Implications
Nelson, A. R., Fingleton, B., Rothenberg, M. L., & Matrisian, L. M. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.5.1135 · Cited by 1,554
The Role of Oxidative Stress in Carcinogenesis
Klaunig, J. E., & Kamendulis, L. M. (2004) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.44.101802.121851 · Cited by 1,533
Apoptosis control by death and decoy receptors
Ashkenazi, A., & Dixit, V. M. (1999) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(99)80034-9 · Cited by 1,288
The role of the cyclin-dependent kinase inhibitor p21 in apoptosis.
Gartel, A. L., & Tyner, A. L. (2002) · PubMed · Cited by 1,076
Pathways of apoptotic and non-apoptotic death in tumour cells
Okada, H., & Mak, T. W. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1412 · Cited by 1,044
Korsmeyer, S. J., Wei, M. C., Saito, M., Weiler, S., Oh, K. J., & Schlesinger, P. H. (2000) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4400783 · Cited by 1,034
Huber, M. A., Azoitei, N., Baumann, B., Grünert, S., Sommer, A., Pehamberger, H., Kraut, N., Beug, H., & Wirth, T. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200421358 · Cited by 1,033
Chronic Inflammation and Oxidative Stress as a Major Cause of Age- Related Diseases and Cancer
Khansari, N., Shakiba, Y., & Mahmoudi, M. (2009) · Recent Patents on Inflammation & Allergy Drug Discovery · doi:10.2174/187221309787158371 · Cited by 921
Reactive Oxygen Species: A Breath of Life or Death?
Fruehauf, J. P., & Meyskens, F. L. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-06-2082 · Cited by 915
Oncogenic CARD11 Mutations in Human Diffuse Large B Cell Lymphoma
Lenz, G., Davis, R. E., Ngo, V. N., Lam, L., George, T. C., Wright, G. W., Dave, S. S., Zhao, H., Xu, W., Rosenwald, A., et al. (2008) · Science · doi:10.1126/science.1153629 · Cited by 867
Resveratrol: A molecule whose time has come? And gone?
Soleas, G. J., Diamandis, E. P., & Goldberg, D. M. (1997) · Clinical Biochemistry · doi:10.1016/s0009-9120(96)00155-5 · Cited by 849
Recent Advances in Chemoprevention of Cancer
Hong, W. K., & Sporn, M. B. (1997) · Science · doi:10.1126/science.278.5340.1073 · Cited by 827
Distinct Caspase Cascades Are Initiated in Receptor-mediated and Chemical-induced Apoptosis
Sun, X.-M., MacFarlane, M., Zhuang, J., Wolf, B. B., Green, D. R., & Cohen, G. M. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.8.5053 · Cited by 820
DNA damage responses to oxidative stress
Barzilai, A., & Yamamoto, K.-I. (2004) · DNA Repair · doi:10.1016/j.dnarep.2004.03.002 · Cited by 796
Aggarwal, B. B., Vijayalekshmi, R. V., & Sung, B. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-0149 · Cited by 795
NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
Fan, Y., Mao, R., & Yang, J. (2013) · Protein & Cell · doi:10.1007/s13238-013-2084-3 · Cited by 776
Brown, V. A., Patel, K. R., Viskaduraki, M., Crowell, J. A., Perloff, M., Booth, T. D., Vasilinin, G., Sen, A., Schinas, A. M., Piccirilli, G., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2364 · Cited by 688
Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses
Leonard, S. S., Xia, C., Jiang, B.-H., Stinefelt, B., Klandorf, H., Harris, G. K., & Shi, X. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.08.105 · Cited by 681
The role of mitochondrial factors in apoptosis: a Russian roulette with more than one bullet
van Loo, G., Saelens, X., van Gurp, M., MacFarlane, M., Martin, S. J., & Vandenabeele, P. (2002) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401088 · Cited by 665
Jeandet, P., Douillet-Breuil, A.-C., Bessis, R., Debord, S., Sbaghi, M., & Adrian, M. (2002) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf011429s · Cited by 646
Targeting the STAT3 signaling pathway in cancer: Role of synthetic and natural inhibitors
Siveen, K. S., Sikka, S., Surana, R., Dai, X., Zhang, J., Kumar, A. P., Tan, B. K. H., Sethi, G., & Bishayee, A. (2014) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2013.12.005 · Cited by 634
Self-citationClinical Pharmacology of Resveratrol and Its Metabolites in Colorectal Cancer Patients
Patel, K. R., Brown, V. A., Jones, D. J. L., Britton, R. G., Hemingway, D., Miller, A. S., West, K. P., Booth, T. D., Perloff, M., Crowell, J. A., et al. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-2027 · Cited by 624
Clément, M.-V., Hirpara, J. L., Chawdhury, S.-H., & Pervaiz, S. (1998) · Blood · doi:10.1182/blood.v92.3.996 · Cited by 611
Chua, H. L., Bhat-Nakshatri, P., Clare, S. E., Morimiya, A., Badve, S., & Nakshatri, H. (2007) · Oncogene · doi:10.1038/sj.onc.1209808 · Cited by 596
Resveratrol bioavailability and toxicity in humans
Cottart, C., Nivet‐Antoine, V., Laguillier‐Morizot, C., & Beaudeux, J. (2010) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.200900437 · Cited by 592
Wang, S., Su, R., Nie, S., Sun, M., Zhang, J., Wu, D., & Moustaid-Moussa, N. (2014) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2013.10.002 · Cited by 531
Cancer Prevention and Treatment with Resveratrol: From Rodent Studies to Clinical Trials
Bishayee, A. (2009) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-08-0160 · Cited by 528
Self-citationClinical trials of resveratrol
Patel, K. R., Scott, E., Brown, V. A., Gescher, A. J., Steward, W. P., & Brown, K. (2011) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05853.x · Cited by 522
Resveratrol and cancer: focus on in vivo evidence
Carter, L. G., D'Orazio, J. A., & Pearson, K. J. (2014) · Endocrine-Related Cancer · doi:10.1530/erc-13-0171 · Cited by 522
Nrf2 as a novel molecular target for chemoprevention
Lee, J.-S., & Surh, Y.-J. (2005) · Cancer Letters · doi:10.1016/j.canlet.2004.09.042 · Cited by 516
The Multifaceted Role of Curcumin in Cancer Prevention and Treatment
Shanmugam, M., Rane, G., Kanchi, M., Arfuso, F., Chinnathambi, A., Zayed, M., Alharbi, S., Tan, B., Kumar, A., & Sethi, G. (2015) · Molecules · doi:10.3390/molecules20022728 · Cited by 510
Self-citationAnticancer therapy targeting the apoptotic pathway
Hu, W., & Kavanagh, J. J. (2003) · The Lancet Oncology · doi:10.1016/s1470-2045(03)01277-4 · Cited by 510
Regulation of EMT by TGFβ in cancer
Heldin, C.-H., Vanlandewijck, M., & Moustakas, A. (2012) · FEBS Letters · doi:10.1016/j.febslet.2012.02.037 · Cited by 505
Bergh, J. J., Lin, H.-Y., Lansing, L., Mohamed, S. N., Davis, F. B., Mousa, S., & Davis, P. J. (2005) · Endocrinology · doi:10.1210/en.2005-0102 · Cited by 497
Nrf2: friend or foe for chemoprevention?
Kensler, T. W., & Wakabayashi, N. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp231 · Cited by 484
Cancer chemopreventive and therapeutic potential of resveratrol: Mechanistic perspectives
Kundu, J. K., & Surh, Y.-J. (2008) · Cancer Letters · doi:10.1016/j.canlet.2008.03.057 · Cited by 473
Resveratrol and Clinical Trials: The Crossroad from In Vitro Studies to Human Evidence
Tomé-Carneiro, J., Larrosa, M., González-Sarrías, A., Tomás-Barberán, F., García-Conesa, M., & Espín, J. (2013) · Current Pharmaceutical Design · doi:10.2174/13816128113199990407 · Cited by 449
Kode, A., Rajendrasozhan, S., Caito, S., Yang, S.-R., Megson, I. L., & Rahman, I. (2008) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00361.2007 · Cited by 447
Howells, L. M., Berry, D. P., Elliott, P. J., Jacobson, E. W., Hoffmann, E., Hegarty, B., Brown, K., Steward, W. P., & Gescher, A. J. (2011) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-11-0148 · Cited by 444
Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential
Caltagirone, S., Rossi, C., Poggi, A., Ranelletti, F. O., Natali, P. G., Brunetti, M., Aiello, F. B., & Piantelli, M. (2000) · International Journal of Cancer · doi:10.1002/1097-0215(20000815)87:4<595::aid-ijc21>3.0.co;2-5 · Cited by 437
Banerjee, S., Bueso-Ramos, C., & Aggarwal, B. B. (2002) · PubMed · Cited by 423
Nuclear Factor-κB Activation: From Bench to Bedside
Sethi, G., Sung, B., & Aggarwal, B. B. (2008) · Experimental Biology and Medicine · doi:10.3181/0707-mr-196 · Cited by 417
Self-citationMartinez, J., & Moreno, J. J. (2000) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00380-9 · Cited by 408
STAT3 SIGNALING: Anticancer Strategies and Challenges
Johnston, P. A., & Grandis, J. R. (2011) · Molecular Interventions · doi:10.1124/mi.11.1.4 · Cited by 406
Bhardwaj, A., Sethi, G., Vadhan-Raj, Bueso-Ramos, C., Takada, Y., Gaur, U., Nair, A. S., Shishodia, S., & Aggarwal, B. B. (2007) · Blood · doi:10.1182/blood-2006-02-003988 · Cited by 395
Self-citationShe, Q., Bode, A. M., Ma, W., Chen, N. Y., & Dong, Z. (2001) · PubMed · Cited by 393
Inhibition of cancer growth by resveratrol is related to its low bioavailability
Asensi, M., Medina, I., Ortega, A., Carretero, J., Baño, M. C., Obrador, E., & Estrela, J. M. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00911-5 · Cited by 388 · cited 1×
“Nevertheless, resveratrol did not reduce the tumor growth of other melanoma cell lines, including A375, B16M, and DM738 xenografts in mice [246,247].”
BackgroundAnsari, K. A., Vavia, P. R., Trotta, F., & Cavalli, R. (2011) · AAPS PharmSciTech · doi:10.1208/s12249-011-9584-3 · Cited by 381
NF‐κB and epithelial to mesenchymal transition of cancer
Min, C., Eddy, S. F., Sherr, D. H., & Sonenshein, G. E. (2008) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21695 · Cited by 376
Ruggeri, B. A., Camp, F., & Miknyoczki, S. (2014) · Biochemical Pharmacology · doi:10.1016/j.bcp.2013.06.020 · Cited by 365
Diet, nutrition, and avoidable cancer.
Willett, W. C. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s8165 · Cited by 365
Anti-inflammatory effects of resveratrol in lung epithelial cells: molecular mechanisms
Donnelly, L. E., Newton, R., Kennedy, G. E., Fenwick, P. S., Leung, R. H. F., Ito, K., Russell, R. E. K., & Barnes, P. J. (2004) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00110.2004 · Cited by 361
Bioactive natural products in cancer prevention and therapy: Progress and promise
Bishayee, A., & Sethi, G. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.08.006 · Cited by 354
Self-citationResveratrol induces apoptosis and inhibits angiogenesis in human breast cancer xenografts in vivo
Garvin, S., Öllinger, K., & Dabrosin, C. (2006) · Cancer Letters · doi:10.1016/j.canlet.2005.01.031 · Cited by 351
Kannaiyan, R., Shanmugam, M. K., & Sethi, G. (2011) · Cancer Letters · doi:10.1016/j.canlet.2010.10.025 · Cited by 346
Self-citationThe red wine antioxidant resveratrol protects isolated rat hearts from ischemia reperfusion injury
Ray, P. S., Maulik, G., Cordis, G. A., Bertelli, A. A. E., Bertelli, A., & Das, D. K. (1999) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(99)00063-5 · Cited by 343
Schneider, Y., Vincent, F., Duranton, B., Badolo, L., Gossé, F., Bergmann, C., Seiler, N., & Raul, F. (2000) · Cancer Letters · doi:10.1016/s0304-3835(00)00511-5 · Cited by 341
Enhancing the bioavailability of resveratrol by combining it with piperine
Johnson, J. J., Nihal, M., Siddiqui, I. A., Scarlett, C. O., Bailey, H. H., Mukhtar, H., & Ahmad, N. (2011) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201100117 · Cited by 339
Regulation of Snail transcription during epithelial to mesenchymal transition of tumor cells
Barberà, M. J., Puig, I., Domínguez, D., Julien-Grille, S., Guaita-Esteruelas, S., Peiró, S., Baulida, J., Francí, C., Dedhar, S., Larue, L., et al. (2004) · Oncogene · doi:10.1038/sj.onc.1207990 · Cited by 337
Brâkenhielm, E., Cao, R., & Cao, Y. (2001) · The FASEB Journal · doi:10.1096/fj.01-0028fje · Cited by 334
Multifaceted link between cancer and inflammation
Sethi, G., Shanmugam, M. K., Ramachandran, L., Kumar, A. P., & Tergaonkar, V. (2012) · Bioscience Reports · doi:10.1042/bsr20100136 · Cited by 333
Self-citationEstrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
Bhat, K., Lantvit, D. D., Christov, K. T., Mehta, R. G., Moon, R. C., & Pezzuto, J. M. (2001) · PubMed · Cited by 330
Resveratrol Modulates Drug- and Carcinogen-Metabolizing Enzymes in a Healthy Volunteer Study
Chow, H.-H. S., Garland, L. L., Hsu, C.-H., Vining, D. R., Chew, W. M., Miller, J. A., Perloff, M., Crowell, J. A., & Alberts, D. S. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0155 · Cited by 330
Fas Ligand-independent, FADD-mediated Activation of the Fas Death Pathway by Anticancer Drugs
Micheau, O., Solary, E., Hammann, A., & Dimanche-Boitrel, M.-T. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.12.7987 · Cited by 320
Dörrie, J., Gerauer, H., Wachter, Y., & Zunino, S. J. (2001) · PubMed · Cited by 319
Csaki, C., Mobasheri, A., & Shakibaei, M. (2009) · Arthritis Research & Therapy · doi:10.1186/ar2850 · Cited by 318
Ahmad, N., Adhami, V. M., Afaq, F., Feyes, D. K., & Mukhtar, H. (2001) · PubMed · Cited by 318
Kimura, Y., & Okuda, H. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.6.1844 · Cited by 313
Shankar, S., Nall, D., Tang, S.-N., Meeker, D., Passarini, J., Sharma, J., & Srivastava, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0016530 · Cited by 304
Wadsworth, T. L., & Koop, D. R. (1999) · Biochemical Pharmacology · doi:10.1016/s0006-2952(99)00002-7 · Cited by 302
Fu, Y., Chang, H., Peng, X., Bai, Q., Yi, L., Zhou, Y., Zhu, J., & Mi, M. (2014) · PLoS ONE · doi:10.1371/journal.pone.0102535 · Cited by 295
Delmas, D., Rébé, C., Lacour, S., Filomenko, R., Athias, A., Gambert, P., Cherkaoui-Malki, M., Jannin, B., Dubrez-Daloz, L., Latruffe, N., et al. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m304896200 · Cited by 291
Tessitore, L., Davit, A., Sarotto, I., & Caderni, G. (2000) · Carcinogenesis · doi:10.1093/carcin/21.5.619 · Cited by 282
Shrimali, D., Shanmugam, M. K., Kumar, A. P., Zhang, J., Tan, B. K. H., Ahn, K. S., & Sethi, G. (2013) · Cancer Letters · doi:10.1016/j.canlet.2013.08.023 · Cited by 277
Self-citationFarnebo, M., Bykov, V. J. N., & Wiman, K. G. (2010) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2010.02.152 · Cited by 268
Screening of potential chemopreventive agents using biochemical markers of carcinogenesis.
Sharma, S., Stutzman, J. D., Kelloff, G. J., & Steele, V. E. (1994) · PubMed · Cited by 264
Targeting transcription factor STAT3 for cancer prevention and therapy
Chai, E. Z. P., Shanmugam, M. K., Arfuso, F., Dharmarajan, A., Wang, C., Kumar, A. P., Samy, R. P., Lim, L. H. K., Wang, L., Goh, B. C., et al. (2016) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2015.10.004 · Cited by 263
Self-citationAfaq, F., Adhami, V. M., & Ahmad, N. (2003) · Toxicology and Applied Pharmacology · doi:10.1016/s0041-008x(02)00014-5 · Cited by 262
la Porte, C., Voduc, N., Zhang, G., Seguin, I., Tardiff, D., Singhal, N., & Cameron, D. W. (2010) · Clinical Pharmacokinetics · doi:10.2165/11531820-000000000-00000 · Cited by 261
Resveratrol for breast cancer prevention and therapy: Preclinical evidence and molecular mechanisms
Sinha, D., Sarkar, N., Biswas, J., & Bishayee, A. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2015.11.001 · Cited by 258
Self-citationResveratrol, a Natural Product Present in Wine, Decreases Tumour Growth in a Rat Tumour Model
Carbó, N., Costelli, P., Baccino, F. M., López-Soriano, F. J., & Argilés, J. M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1998.9916 · Cited by 257
Resveratrol: review on therapeutic potential and recent advances in drug delivery
Pangeni, R., Sahni, J. K., Ali, J., Sharma, S., & Baboota, S. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2014.919253 · Cited by 255
Metabolism of chemical carcinogens
Guengerich, F. P. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.345 · Cited by 255
A comparison of the anticarcinogenic properties of four red wine polyphenols
Soleas, G. J., Grass, L., Josephy, P. D., Goldberg, D. M., & Diamandis, E. P. (2002) · Clinical Biochemistry · doi:10.1016/s0009-9120(02)00275-8 · Cited by 251
Holcombe, R. F., Nguyen, A., Martinez, Stamos, M. J., Moyer, M. P., Planutis, K., Hope, & Holcombe, R. F. (2009) · Cancer Management and Research · doi:10.2147/cmar.s4544 · Cited by 248
Sgambato, A., Ardito, R., Faraglia, B., Boninsegna, A., Wolf, F. I., & Cittadini, A. (2001) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/s1383-5718(01)00232-7 · Cited by 244
Zhu, W., Qin, W., Zhang, K., Rottinghaus, G. E., Chen, Y.-C., Kliethermes, B., & Sauter, E. R. (2012) · Nutrition and Cancer · doi:10.1080/01635581.2012.654926 · Cited by 241
Kapadia, G. J., Azuine, M. A., Tokuda, H., Takasaki, M., Mukainaka, T., Konoshima, T., & Nishino, H. (2002) · Pharmacological Research · doi:10.1006/phrs.2002.0992 · Cited by 238
Wolter, F., Akoglu, B., Clausnitzer, A., & Stein, J. (2001) · The Journal of Nutrition · doi:10.1093/jn/131.8.2197 · Cited by 236
Shanmugam, M. K., Kannaiyan, R., & Sethi, G. (2011) · Nutrition and Cancer · doi:10.1080/01635581.2011.523502 · Cited by 235
Self-citationCiolino, H. P., & Yeh, G. C. (1999) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12538-2 · Cited by 233
Harikumar, K. B., Kunnumakkara, A. B., Sethi, G., Diagaradjane, P., Anand, P., Pandey, M. K., Gelovani, J., Krishnan, S., Guha, S., & Aggarwal, B. B. (2010) · International Journal of Cancer · doi:10.1002/ijc.25041 · Cited by 231
Self-citationShanmugam, M. K., Lee, J. H., Chai, E. Z. P., Kanchi, M. M., Kar, S., Arfuso, F., Dharmarajan, A., Kumar, A. P., Ramar, P. S., Looi, C. Y., et al. (2016) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2016.03.005 · Cited by 230
Self-citationSmoliga, J., & Blanchard, O. (2014) · Molecules · doi:10.3390/molecules191117154 · Cited by 229
Molecular mechanism of the chemopreventive effect of resveratrol
Dong, Z. (2003) · Mutation Research - Fundamental and Molecular Mechanisms of Mutagenesis · doi:10.1016/s0027-5107(02)00330-5 · Cited by 227
Popat, R., Plesner, T., Davies, F., Cook, G., Cook, M., Elliott, P., Jacobson, E., Gumbleton, T., Oakervee, H., & Cavenagh, J. (2013) · British Journal of Haematology · doi:10.1111/bjh.12154 · Cited by 226
Cancer Chemoprevention and Apoptosis Mechanisms Induced by Dietary Polyphenolics
Galati, Teng, Moridani, Chan, & O'Brien (2000) · Drug Metabolism and Drug Interactions · doi:10.1515/dmdi.2000.17.1-4.311 · Cited by 225
Pozo‐Guisado, E., Merino, J. M., Mulero‐Navarro, S., Lorenzo‐Benayas, M. J., Centeno, F., Alvarez‐Barrientos, A., & Salguero, P. M. F. (2005) · International Journal of Cancer · doi:10.1002/ijc.20856 · Cited by 223
Chemoprevention of skin cancer by grape constituent resveratrol: relevance to human disease?
Aziz, M. H., Reagan‐Shaw, S., Wu, J., Longley, B. J., & Ahmad, N. (2005) · The FASEB Journal · doi:10.1096/fj.04-3582fje · Cited by 220
Shanmugam, M. K., Nguyen, A. H., Kumar, A. P., Tan, B. K. H., & Sethi, G. (2012) · Cancer Letters · doi:10.1016/j.canlet.2012.02.037 · Cited by 219
Self-citationResveratrol Suppresses Colitis and Colon Cancer Associated with Colitis
Cui, X., Jin, Y., Hofseth, A. B., Pena, E., Habiger, J., Chumanevich, A., Poudyal, D., Nagarkatti, M., Nagarkatti, P. S., Singh, U. P., et al. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0117 · Cited by 219
Oxidative Stress and Carbonyl Lesions in Ulcerative Colitis and Associated Colorectal Cancer
Wang, Z., Li, S., Cao, Y., Tian, X., Zeng, R., Liao, D.-F., & Cao, D. (2016) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2016/9875298 · Cited by 219
Resveratrol Suppresses the Angiogenesis and Tumor Growth of Gliomas in Rats
Tseng, S.-H., Lin, S.-M., Chen, J.-C., Su, Y.-H., Huang, H.-Y., Chen, C.-K., Lin, P.-Y., & Chen, Y. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0105 · Cited by 217
Nguyen, A. V., Martinez, M. E., Stamos, M. J., Moyer, M. P., Planutis, K., Hope, C., & Holcombe, R. F. (2009) · PubMed Central · Cited by 216
Maier, H. J., Schmidt-Straßburger, U., Huber, M. A., Wiedemann, E. M., Beug, H., & Wirth, T. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.03.003 · Cited by 215
Potential Role of Natural Compounds as Anti-Angiogenic Agents in Cancer
Shanmugam, M. K., Warrier, S., Kumar, A. P., Sethi, G., & Arfuso, F. (2017) · Current Vascular Pharmacology · doi:10.2174/1570161115666170713094319 · Cited by 213
Self-citationChiou, Y.-S., Tsai, M.-L., Nagabhushanam, K., Wang, Y.-J., Wu, C.-H., Ho, C.-T., & Pan, M.-H. (2011) · Journal of Agricultural and Food Chemistry · doi:10.1021/jf2000103 · Cited by 205
Resveratrol in the chemoprevention and treatment of hepatocellular carcinoma
Bishayee, A., Politis, T., & Darvesh, A. S. (2010) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2009.10.002 · Cited by 204
Self-citationMann, A. P., Verma, A., Sethi, G., Manavathi, B., Wang, H., Fok, J. Y., Kunnumakkara, A. B., Kumar, R., Aggarwal, B. B., & Mehta, K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-1457 · Cited by 203
Self-citationJi, Q., Liu, X., Han, Z., Zhou, L., Sui, H., Yan, L., Jiang, H., Ren, J., Cai, J., & Li, Q. (2015) · BMC Cancer · doi:10.1186/s12885-015-1119-y · Cited by 203
Aggarwal, B. B., Van Kuiken, M. E., Iyer, L. H., Harikumar, K. B., & Sung, B. (2009) · Experimental Biology and Medicine · doi:10.3181/0902-mr-78 · Cited by 203
Analysis of the intricate relationship between chronic inflammation and cancer
Chai, E. Z. P., Siveen, K. S., Shanmugam, M. K., Arfuso, F., & Sethi, G. (2015) · Biochemical Journal · doi:10.1042/bj20141337 · Cited by 202
Self-citationSchneider, Y., Duranton, B., Goss, F., Schleiffer, R., Seiler, N., & Raul, F. (2001) · Nutrition and Cancer · doi:10.1207/s15327914nc391_14 · Cited by 202
Naik, P., Karrim, J., & Hanahan, D. (1996) · Genes & Development · doi:10.1101/gad.10.17.2105 · Cited by 202
Stagos, D., Portesis, N., Spanou, C., Mossialos, D., Aligiannis, N., Chaita, E., Panagoulis, C., Reri, E., Skaltsounis, L., Tsatsakis, A. M., et al. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.08.033 · Cited by 201
Geiszt, M., Lekstrom, K., Brenner, S., Hewitt, S. M., Dana, R., Malech, H. L., & Leto, T. L. (2003) · The Journal of Immunology · doi:10.4049/jimmunol.171.1.299 · Cited by 201
Aziz, M. H., Nihal, M., Fu, V. X., Jarrard, D. F., & Ahmad, N. (2006) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-05-0526 · Cited by 201
Li, F., Zhang, J., Arfuso, F., Chinnathambi, A., Zayed, M. E., Alharbi, S. A., Kumar, A. P., Ahn, K. S., & Sethi, G. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1470-4 · Cited by 198
Self-citationChemoprevention of liver cancer by plant polyphenols
Stagos, D., Amoutzias, G. D., Matakos, A., Spyrou, A., Tsatsakis, A. M., & Kouretas, D. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.04.002 · Cited by 197
Chen, Q., Ganapathy, S., Singh, K. P., Shankar, S., & Srivastava, R. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015288 · Cited by 190
Bai, Y., Mao, Q., Qin, J., Zheng, X., Wang, Y., Yang, K., Shen, H., & Xie, L. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2009.01415.x · Cited by 189
Benitez, D. A., Pozo‐Guisado, E., Alvarez‐Barrientos, A., Fernandez‐Salguero, P. M., & Castellón, E. A. (2007) · Journal of Andrology · doi:10.2164/jandrol.106.000968 · Cited by 186
van Ginkel, P. R., Sareen, D., Subramanian, L., Walker, Q., Darjatmoko, S. R., Lindstrom, M. J., Kulkarni, A., Albert, D. M., & Polans, A. S. (2007) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-0347 · Cited by 185
Tinhofer, I., Bernhard, D., Senfter, M., Anether, G., Loeffler, M., Kroemer, G., Kofler, R., Csordas, A., & Greil, R. (2001) · The FASEB Journal · doi:10.1096/fj.00-0675fje · Cited by 183
Filippi-Chiela, E. C., Villodre, E. S., Zamin, L. L., & Lenz, G. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020849 · Cited by 181
Baek, S. H., Ko, J.-H., Lee, H., Jung, J., Kong, M., Lee, J.-W., Lee, J., Chinnathambi, A., Zayed, M., Alharbi, S. A., et al. (2016) · Phytomedicine · doi:10.1016/j.phymed.2016.02.011 · Cited by 181
Self-citationNeergheen, V. S., Bahorun, T., Taylor, E. W., Jen, L.-S., & Aruoma, O. I. (2010) · Toxicology · doi:10.1016/j.tox.2009.10.010 · Cited by 179
Targeting the PI3K/Akt signaling pathway in gastric carcinoma: A reality for personalized medicine?
Singh, S. S. (2015) · World Journal of Gastroenterology · doi:10.3748/wjg.v21.i43.12261 · Cited by 179
Chen, Z.-H. (2004) · Carcinogenesis · doi:10.1093/carcin/bgh183 · Cited by 175
Cai, H., Scott, E., Kholghi, A., Andreadi, C., Rufini, A., Karmokar, A., Britton, R. G., Horner-Glister, E., Greaves, P., Jawad, D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aaa7619 · Cited by 174
Resveratrol: From Basic Science to the Clinic
Cucciolla, V., Borriello, A., Oliva, A., Galletti, P., Zappia, V., & Ragione, F. D. (2007) · Cell Cycle · doi:10.4161/cc.6.20.4815 · Cited by 174
Revel, A., Raanani, H., Younglai, E., Xu, J., Rogers, I., Han, R., Savouret, J., & Casper, R. F. (2003) · Journal of Applied Toxicology · doi:10.1002/jat.916 · Cited by 174
Cao, Z., Fang, J., Xia, C., Shi, X., & Jiang, B.-H. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0588 · Cited by 173
Potential pharmacological control of the NF-κB pathway
Sethi, G., & Tergaonkar, V. (2009) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2009.03.004 · Cited by 171
Self-citationLi, W., Ma, J., Ma, Q., Li, B., Han, L., Liu, J., Xu, Q., Duan, W., Yu, S., Wang, F., et al. (2013) · Current Medicinal Chemistry · doi:10.2174/09298673113209990251 · Cited by 171
Li, Z. G. (2002) · Carcinogenesis · doi:10.1093/carcin/23.9.1531 · Cited by 169
Epithelial-Mesenchymal Transition: NF-κB Takes Center Stage
Huber, M. A., Beug, H., & Wirth, T. (2004) · Cell Cycle · doi:10.4161/cc.3.12.1280 · Cited by 168
Bishayee, A., & Dhir, N. (2009) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2008.11.015 · Cited by 167
Self-citationSale, S., Tunstall, R. G., Ruparelia, K. C., Potter, G. A., Steward, W. P., & Gescher, A. J. (2005) · International Journal of Cancer · doi:10.1002/ijc.20884 · Cited by 165
Bloomston, M., Zervos, E. E., & Rosemurgy, A. S. (2002) · Annals of Surgical Oncology · doi:10.1007/bf02574483 · Cited by 165
Miura, D., Miura, Y., & Yagasaki, K. (2003) · Life Sciences · doi:10.1016/s0024-3205(03)00469-7 · Cited by 165
Wang, H., Zhang, H., Tang, L., Chen, H., Wu, C., Zhao, M., Yang, Y., Chen, X., & Liu, G. (2013) · Toxicology · doi:10.1016/j.tox.2012.09.017 · Cited by 165
Bishayee, A., Barnes, K. F., Bhatia, D., Darvesh, A. S., & Carroll, R. T. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0171 · Cited by 163
Self-citationJazirehi, A. R., & Bonavida, B. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.71.3.1 · Cited by 163
Delmas, D., Solary, E., & Latruffe, N. (2011) · Current Medicinal Chemistry · doi:10.2174/092986711795029708 · Cited by 161
Resveratrol suppresses prostate cancer progression in transgenic mice
Harper, C. E., Patel, B. B., Wang, J., Arabshahi, A., Eltoum, I. A., & Lamartiniere, C. A. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm144 · Cited by 160
Hecht, S. S., Kenney, P. M. J., Wang, M., Trushin, N., Agarwal, S., Venket Rao, A., & Upadhyaya, P. (1999) · Cancer Letters · doi:10.1016/s0304-3835(98)00326-7 · Cited by 159
Aziz, M. H., Afaq, F., & Ahmad, N. (2004) · Photochemistry and Photobiology · doi:10.1562/2004-08-13-ra-274.1 · Cited by 159
Byrum, R. S., Goulet, J. L., Snouwaert, J. N., Griffiths, R., & Koller, B. H. (1999) · The Journal of Immunology · doi:10.4049/jimmunol.163.12.6810 · Cited by 159
Reagan-Shaw, S., Afaq, F., Aziz, M. H., & Ahmad, N. (2004) · Oncogene · doi:10.1038/sj.onc.1207666 · Cited by 158
Lin, H., Shih, A., Davis, F. B., Tang, H.-Y., Martino, L. J., Bennett, J. A., & Davis, P. J. (2002) · The Journal of Urology · doi:10.1016/s0022-5347(05)64739-8 · Cited by 157
Windmill, K., McKinnon, R. A., Zhu, X., Gaedigk, A., Grant, D. M., & McManus, M. E. (1997) · Mutation research. Fundamental and molecular mechanisms of mutagenesis · doi:10.1016/s0027-5107(97)00038-9 · Cited by 154
Bernhard, D., Tinhofer, I., Tonko, M., Hübl, H., Ausserlechner, M. J., Greil, R., Kofler, R., & Csordás, A. (2000) · Cell Death and Differentiation · doi:10.1038/sj.cdd.4400719 · Cited by 154
Jang, M., & Pezzuto, J. M. (1998) · Cancer Letters · doi:10.1016/s0304-3835(98)00250-x · Cited by 152
Ferry‐Dumazet, H., Garnier, O., Mamani‐Matsuda, M., Vercauteren, J., Belloc, F., Billiard, C., Dupouy, M., Thiolat, D., Kolb, J. P., Marit, G., et al. (2002) · Carcinogenesis · doi:10.1093/carcin/23.8.1327 · Cited by 152
Resveratrol inhibits glucose metabolism in human ovarian cancer cells
Kueck, A. S., Opipari, A. W., Griffith, K. A., Tan, L., Choi, M., Huang, J. T., Wahl, H. N., & Liu, J. R. (2007) · Gynecologic Oncology · doi:10.1016/j.ygyno.2007.07.065 · Cited by 149
Key cell signaling pathways modulated by zerumbone: Role in the prevention and treatment of cancer
Prasannan, R., Kalesh, K., Shanmugam, M. K., Nachiyappan, A., Ramachandran, L., Nguyen, A. H., Kumar, A. P., Lakshmanan, M., Ahn, K. S., & Sethi, G. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.07.015 · Cited by 145
Self-citationSchlachterman, A., Valle, F., Wall, K. M., Azios, N. G., Castillo, L., Morell, L., Washington, A. V., Cubano, L. A., & Dharmawardhane, S. F. (2008) · Translational Oncology · doi:10.1593/tlo.07100 · Cited by 144
Krepler, C., Xiao, M., Sproesser, K., Brafford, P. A., Shannan, B., Beqiri, M., Liu, Q., Xu, W., Garman, B., Nathanson, K. L., et al. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-1762 · Cited by 144
Curcumin and Resveratrol in the Management of Cognitive Disorders: What is the Clinical Evidence?
Mazzanti, G., & Giacomo, S. D. (2016) · Molecules · doi:10.3390/molecules21091243 · Cited by 143
Yang, Q., Wang, B., Zang, W., Wang, X., Liu, Z., Li, W., & Jia, J. (2013) · PLoS ONE · doi:10.1371/journal.pone.0070627 · Cited by 142
Roy, S. K., Chen, Q., Fu, J., Shankar, S., & Srivastava, R. K. (2011) · PLoS ONE · doi:10.1371/journal.pone.0025166 · Cited by 140
Beedanagari, S. R., Bebenek, I. G., Bui, P. H., & Hankinson, O. (2009) · Toxicological Sciences · doi:10.1093/toxsci/kfp079 · Cited by 140
Yu, R., Hebbar, V., Kim, D. W., Mandlekar, S., Pezzuto, J. M., & Kong, A.-N. T. (2001) · Molecular Pharmacology · doi:10.1124/mol.60.1.217 · Cited by 140
Environmental factors as regulators and effectors of multistep carcinogenesis
Minamoto, T., Mai, M., & Ronai, Z. A. (1999) · Carcinogenesis · doi:10.1093/carcin/20.4.519 · Cited by 139
Resveratrol, but not EGCG, in the diet suppresses DMBA-induced mammary cancer in rats.
Whitsett, T. G., Carpenter, M., & Lamartiniere, C. A. (2006) · Journal of Carcinogenesis · doi:10.1186/1477-3163-5-15 · Cited by 137
SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol
Boily, G., He, X. H., Pearce, B., Jardine, K. E., & McBurney, M. W. (2009) · Oncogene · doi:10.1038/onc.2009.147 · Cited by 137
Saud, S. M., Li, W., Morris, N. L., Matter, M. S., Colburn, N. H., Kim, Y. S., & Young, M. R. (2014) · Carcinogenesis · doi:10.1093/carcin/bgu209 · Cited by 135
Murugan, S., Viswanathan, P., & Nalini, N. (2005) · Carcinogenesis · doi:10.1093/carcin/bgi286 · Cited by 135
Paller, C. J., Rudek, M. A., Zhou, X. C., Wagner, W. D., Hudson, T., Anders, N. M., Hammers, H. J., Dowling, D., King, S., Antonarakis, E. S., et al. (2015) · The Prostate · doi:10.1002/pros.23024 · Cited by 135
Influence of hypothermia on post-ischemic inflammation: Role of nuclear factor kappa B (NFκB)
Yenari, M. A., & Han, H. S. (2006) · Neurochemistry International · doi:10.1016/j.neuint.2006.03.016 · Cited by 134
Yu, Y.-H., Chen, H.-A., Chen, P.-S., Cheng, Y.-J., Hsu, W.-H., Chang, Y.-W., Chen, Y.-H., Jan, Y., Hsiao, M., Chang, T.-Y., et al. (2012) · Oncogene · doi:10.1038/onc.2012.74 · Cited by 134
Nuclear Factor-Kappa B: From Clone to Clinic
Ahn, K., Sethi, G., & Aggarwal, B. B. (2007) · Current Molecular Medicine · doi:10.2174/156652407782564363 · Cited by 134
Self-citationGanapathy, S., Chen, Q., Singh, K. P., Shankar, S., & Srivastava, R. K. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015627 · Cited by 133
Resveratrol interferes with AKT activity and triggers apoptosis in human uterine cancer cells
Sexton, É., Themsche, C. V., Leblanc, K., Parent, S., Lemoine, P., & Asselin, É. (2006) · Molecular Cancer · doi:10.1186/1476-4598-5-45 · Cited by 131
The effect of leukotrienes B and selected HETEs on the proliferation of colon cancer cells
Bortuzzo, C., Hanif, R., Kashfi, K., Staiano‐Coico, L., Shiff, S. J., & Rigas, B. (1996) · Biochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism · doi:10.1016/0005-2760(96)00003-3 · Cited by 130
Sirerol, J. A., Feddi, F., Mena, S., Rodríguez, M. L., Sirera, P. S., Aupí, M., Pérez, S., Asensi, M. A., Ortega, Á., & Estrela, J. M. (2015) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2015.03.027 · Cited by 130
Cytotoxic and antimutagenic stilbenes from seeds ofPaeonia lactiflora
Kim, H. J., Chang, E. J., Bae, S.-J., Shim, S. M., Park, H. D., Rhee, C. H., Park, J. H., & Choi, S. W. (2002) · Archives of Pharmacal Research · doi:10.1007/bf02976629 · Cited by 128
Effect of Resveratrol on Growth of 4T1 Breast Cancer Cells in Vitro and in Vivo
Bove, K., Lincoln, D. W., & Tsan, M. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6554 · Cited by 128
Lin, H., Tang, H., Keating, T., Wu, Y.-H., Shih, A., Hammond, D., Sun, M., Hercbergs, A. A., Davis, F. B., & Davis, P. J. (2007) · Carcinogenesis · doi:10.1093/carcin/bgm239 · Cited by 128
Chen, Y., Tseng, S., Lai, H., & Chen, W. (2004) · Surgery · doi:10.1016/j.surg.2004.01.017 · Cited by 127
Cited by
Loh, C.-Y., Chai, J., Tang, T., Wong, W., Sethi, G., Shanmugam, M., Chong, P., & Looi, C. (2019) · Cells · doi:10.3390/cells8101118 · Cited by 1,315
Self-citationHealth benefits of polyphenols: A concise review
Rana, A., Samtiya, M., Dhewa, T., Mishra, V., & Aluko, R. E. (2022) · Journal of Food Biochemistry · doi:10.1111/jfbc.14264 · Cited by 761
Medicinal prospects of antioxidants: A review
Neha, K., Haider, M. R., Pathak, A., & Yar, M. S. (2019) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2019.06.010 · Cited by 702
Resveratrol for cancer therapy: Challenges and future perspectives
Ren, B., Kwah, M. X.-Y., Liu, C., Ma, Z., Shanmugam, M. K., Ding, L., Xiang, X., Ho, P. C.-L., Wang, L., Ong, P. S., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.05.001 · Cited by 495
Self-citationMitochondria and Reactive Oxygen Species in Aging and Age-Related Diseases
(2018) · International Review of Cell and Molecular Biology · doi:10.1016/bs.ircmb.2018.05.006 · Cited by 455
Metadata
- Authors
- Ko, J.-H., Sethi, G., Um, J.-Y., Shanmugam, M. K., Arfuso, F., Kumar, A. P., Bishayee, A., & Ahn, K. S.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2017-12-01
- Volume
- 18
- Issue
- 12
- Pages
- 2589
- ISSN
- 1422-0067 (ISSN-L)
- OpenAlex
- W2771136768
- Cited by
- 800
- References
- 319
- FWCI
- 28.81
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.